Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This clinical trial consists of two parts：1. a randomized, double-blind, single-center,
placebo-controlled, dose-escalation PK study; 2. food effects and drug metabolism
transformation study.
The main purpose of this trial is to evaluate the Safety, Tolerance, Pharmacokinetics,
Pharmacodynamics and Food effects of VC005 Tablets in healthy subjects.